METTL14 and atherosclerosis: In addition, studies have revealed that LncRNA ZFAS1/RAB22A in atherosclerosis [34], LINC01320 in gastric cancer [35], Lnc-LSG1 and LncRNA NEAT1 in renal cell carcinoma [36, 37], LncRNA MIR155HG in hepatocellular carcinoma were also regulated by METTL14-mediated m6A modification [38], indicating that METTL14 can regulate the modification of m6A on various LncRNAs, therefore participating in the genesis and development of various tumors.